Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/1998
04/02/1998WO1998013042A1 Antimycotic gel with high active substance release
04/02/1998WO1998013041A1 Prophylaxis and treatment of intestinal tract fluid and electrolyte loss using histidine compositions
04/02/1998WO1998013040A1 Eyedrops
04/02/1998WO1998013039A1 Dfmo for the treatment or prevention of cervical intraepithelial neoplasia
04/02/1998WO1998013038A1 Subepithelial turbidity inhibitor
04/02/1998WO1998013037A1 Methods of using agmatine to reduce intracellular polyamine levels and to inhibit inducible nitric oxide synthase
04/02/1998WO1998013036A1 Pharmaceutical compositions comprising s-alkylisothiouronium derivatives
04/02/1998WO1998013035A1 Percutaneous preparations
04/02/1998WO1998013034A1 Use of sibutramine analogues to lower lipid levels
04/02/1998WO1998013033A1 Medical treatment
04/02/1998WO1998013032A1 Compositions of therapeutic agents suitable for oral administration
04/02/1998WO1998013031A2 Medicinal aerosol formulations comprising budesonide
04/02/1998WO1998013030A1 Biodegradable ionic matrix of variable internal polarity with grafted polymer
04/02/1998WO1998013029A1 Oral delayed immediate release formulation and method of preparation therefor
04/02/1998WO1998013027A1 Coated particle formulation
04/02/1998WO1998013026A1 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules
04/02/1998WO1998013023A1 A product, a method for its production, and its use
04/02/1998WO1998013021A1 Preparation protecting skin from mechanical irritation
04/02/1998WO1998013020A1 Skin care compositions containing combinations of compounds for mimicking the effect on skin of retinoic acid
04/02/1998WO1998013019A1 Skin care compositions containing an acid and a retinoid
04/02/1998WO1998013009A2 Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis
04/02/1998WO1998013007A2 Methods and compositions for lipidization of hydrophilic molecules
04/02/1998WO1998013001A1 Intranasal formulations for promoting sleep and method of using the same
04/02/1998WO1998012910A2 NOVEL CREBa ISOFORM
04/02/1998WO1998005292A3 Piperidine and piperazine derivatives and their use as muscarinic antagonists
04/02/1998WO1998000119A3 Applications of active substances affecting the functions of non neuronal acetylcholine
04/02/1998DE19640556A1 Use of tri:alkyl-xanthine or derivatives for modulating apoptosis
04/02/1998DE19640555A1 Use of isoxazole-amide or croton-amide derivatives to modulate apoptosis
04/02/1998DE19640054A1 Di:nucleotide(s) with modified base, sugar and phosphate groups
04/02/1998DE19639818A1 Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung der Seborrhoischen Dermatitis Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
04/02/1998DE19639817A1 Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung von Hautinfektionen Use of 1-hydroxy-2-pyridones for the treatment of skin infections
04/02/1998DE19639816A1 Antimykotische Mittel mit hoher Wirkstofffreisetzung Antifungal agent with high drug release
04/02/1998DE19639462A1 New sulphonamide derivatives of chroman
04/02/1998CA2814748A1 O2-substituted 1-[(2-carboxylato) pyrrolidin-1-yl] diazen-1-ium-1,2-diolates
04/02/1998CA2705474A1 O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates
04/02/1998CA2658989A1 Tripterygium wilfordii preparations and uses thereof
04/02/1998CA2602802A1 Heterocyclic thioesters and ketones
04/02/1998CA2268958A1 A product, a method for its production, and its use
04/02/1998CA2268945A1 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules
04/02/1998CA2267179A1 Methods and compositions for lipidization of hydrophilic molecules
04/02/1998CA2266929A1 Beta-glucan products and extraction processes from cereals
04/02/1998CA2266898A1 Intranasal formulations for promoting sleep and method of using the same
04/02/1998CA2266642A1 Biodegradable ionic matrix of variable internal polarity with grafted polymer
04/02/1998CA2266627A1 Repellent formulations
04/02/1998CA2266619A1 Non-invasive administration of adeno-associated viral vectors
04/02/1998CA2266615A1 Skin care compositions containing an acid and a retinoid
04/02/1998CA2266448A1 Coated particle formulation
04/02/1998CA2266438A1 Medical treatment
04/02/1998CA2266431A1 Medicinal aerosol formulations comprising budesonide
04/02/1998CA2266419A1 Gene therapy for inhibition of angiogenesis
04/02/1998CA2265996A1 Aryl-substituted acrylamides with leukotriene b4 (ltb-4) receptor antagonist activity
04/02/1998CA2265950A1 Spiro-azacyclic derivatives and their use as therapeutic agents
04/02/1998CA2265053A1 Nitrone derivatives
04/02/1998CA2264158A1 Pharmaceutical compositions and methods of treating compulsive disorders using naaladase inhibitors
04/02/1998CA2264043A1 Naaladase compositions and methods for treating glutamate abnormality and effecting neuronal activity in animals
04/02/1998CA2263925A1 Heterocyclic esters and amides
04/02/1998CA2263479A1 Quinoline derivatives inhibiting the effect of growth factors such as vegf
04/02/1998CA2236154A1 Novel creba isoform
04/02/1998CA2186987A1 Inhibitors of core 2 glcnac-t and use of the inhibitors to prevent or treat cardiomyopathy associated with diabetes
04/01/1998EP0832981A1 DNA sequences to target proteins to the mammary gland for efficient secretion
04/01/1998EP0832980A1 Recombinant therapies for infection and hyperproliferative disorders
04/01/1998EP0832977A2 Novel sugar kinase
04/01/1998EP0832975A2 Histidinol dehydrogenase from Staphylococcus aureus
04/01/1998EP0832973A2 GTP-binding protein
04/01/1998EP0832900A1 Peptide and method of obtaining it
04/01/1998EP0832898A2 Substituted amino acid derivatives
04/01/1998EP0832891A1 Dihydrobenzo (B) indeno (2,1-D) thiophene compounds, intermediates, processes, compositions, and methods
04/01/1998EP0832890A1 Benzo (B) indeno (2,1-D) thiophene compounds, intermediates, processes, compositions, and methods
04/01/1998EP0832888A1 Benzothiophene compounds, compositions, and methods
04/01/1998EP0832887A1 N-acylpiperazine derivative, anti-ulcer drug, and antibacterial drug
04/01/1998EP0832886A1 Flavon derivatives, process for their preparation, and pharmaceutical compositions containing them
04/01/1998EP0832883A1 Tetrahydrobenzo(a)fluorene compounds and methods of use
04/01/1998EP0832882A2 Naphthofluorene compounds, intermediates, compositions, and methods
04/01/1998EP0832881A2 Benzofluorene compounds, intermediates, compositions, and methods
04/01/1998EP0832880A1 Dihydrobenzofluorene compounds, intermediates, compositions, and methods
04/01/1998EP0832875A1 Highly water-soluble metalloproteinase inhibitor
04/01/1998EP0832846A2 Complexes of polymer and hydrogen peroxide
04/01/1998EP0832653A1 Use of cytokines and cytotoxic compounds in a method for treatment of tumours
04/01/1998EP0832652A1 Process of extracting and purifying biologically effective ingredients from combined medicinal plants and their extract composition
04/01/1998EP0832651A1 Inhibitor for lipid peroxide increase
04/01/1998EP0832650A2 Use of serotonin 5-HT1F agonists for the prevention of migraine
04/01/1998EP0832649A1 Antifungal agent
04/01/1998EP0832642A2 Derivatives of Benzoxazole useful as uv filters
04/01/1998EP0832272A1 Cationic lipid:dna complexes for gene targeting
04/01/1998EP0832266A1 Oral delivery of adeno-associated viral vectors
04/01/1998EP0832241A1 Mutants of streptococcal toxin a and methods of use
04/01/1998EP0832232A1 Kunitz type plasma kallikrein inhibitors
04/01/1998EP0832231A2 A C5a-LIKE SEVEN TRANSMEMBRANE RECEPTOR
04/01/1998EP0832227A1 Method for prolonging the expression of a gene of interest using soluble ctla4 molecules
04/01/1998EP0832217A1 Modified steroid hormones for gene therapy and methods for their use
04/01/1998EP0832213A1 TNF-$g(a) RIBOZYMES, TNF-$g(a) RIBOZYME BINDING PROTEIN AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-$g(a) RIBOZYMES
04/01/1998EP0832203A1 Use of neuro-derived fetal cell lines for transplantation therapy
04/01/1998EP0832198A1 Oxygen activatable formulations for disinfection or sterilization
04/01/1998EP0832190A1 Essential oligonucleotides of vertebrate telomerase
04/01/1998EP0832128A2 Thrombin receptor homolog
04/01/1998EP0832102A1 KETOHETEROCYCLIC INHIBITORS OF FACTOR Xa
04/01/1998EP0832099A1 Reversible cysteine protease inhibitors
04/01/1998EP0832094A2 Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (nhe), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the nhe-inhibitory efficacy of compounds
04/01/1998EP0832093A1 Expression of lipoproteins
04/01/1998EP0832092A1 Orally active adenosine kinase inhibitors
1 ... 6671 6672 6673 6674 6675 6676 6677 6678 6679 6680 6681 6682 6683 6684 6685 6686 6687 6688 6689 6690 6691 ... 7860